Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.
Peptinovo Biopharma has raised $1.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.
Peptinovo Biopharma is headquartered in Ann Arbor, United States.
Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects.
Peptinovo Biopharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Peptinovo Biopharma — Funding & Investors." VCBacked, September 24, 2024, https://www.vcbacked.co/company/peptinovo-biopharma. Accessed August 15, 2026.
VCBacked. (2024). Peptinovo Biopharma — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/peptinovo-biopharma
{{cite web |title=Peptinovo Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/peptinovo-biopharma |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated